Greenwood Talks Innovation, Drug Pricing, and the Midterm Elections on ForbesBooks Radio
[ad_1]
During the Forbes Healthcare Summit, BIO CEO Jim Greenwood joined Gregg Stebben, host of ForbesBooks Radio, for a dialogue about innovation happening in the biopharma business, the price and worth of prescription medicines and how the latest midterm elections might influence the drug pricing debate.
“The latest indications are that for every $1 we spend on medicines, we save $2.50 in health care costs,” Greenwood defined. “Those who are [determined] to reduce the costs spent on prescription drugs need to be reminded that if they kill innovation, not only are they destroying the hopes of all of the people desperately waiting for cures and treatments – but they are really, ultimately, going to raise the cost of health care.”
Listen to the entire podcast by clicking the picture beneath.
About the creator
Andrew Segerman is the Manager of Health Communications for the Biotechnology Innovation Organization (BIO). Prior to becoming a member of BIO, Andrew spent practically 4 years supporting the strategic communications crew at America’s Health Insurance Plans. In his spare time, he might be discovered testing the D.C. eating scene together with his spouse or catching a film with Cheddar, his orange cat. Andrew is a New Jersey native and graduated with a level in Communications from the University of Rhode Island.
[ad_2]
